Skip to main content
Lyrea avatar

Not yet reviewed — this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

Citicoline

This article is a stubmissing:
Subjective Effects
Pharmacology
Interactions
Tolerance
History & Culture
Citicoline molecule structureCiticoline molecule structure
Cytidine 5'-diphosphocholine
CDP-choline, Cytidine diphosphate choline
Psychoactive Class
Chemical Class

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold50 mg
Light100-250 mg
Moderate250-1000 mg
Strong1000-2000 mg
Heavy2000+ mg
Bioavailability
98%

Duration

Onset1-2 hours
Come Up2-3 hours
Peak2.5-3.5 hours
Offset30-40 hours
After Effects40-60 hours
Total58-74 hours

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacology not written up yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Addiction & Dependence

Psychological

Extremely Low

Citicoline is not considered habit-forming; interest in repeated use may lessen over time, making use generally self-limiting.

Physical

Extremely Low

Citicoline does not produce physical dependence.

Toxicity

Gastrointestinal

At therapeutic doses, short-lived mild adverse effects are uncommon; when they occur, stomach pain and diarrhea are among the most typical.

Psychosis Risk

Citicoline may exacerbate psychotic episodes in susceptible individuals. A 2020 meta-analysis did not support the hypothesis that chronic citicoline use causes adverse psychiatric effects, though concerns had been raised.

History & Culture

History & Culture not written up yet

Legality

International

Approved, investigational, and withdrawn regulatory listings are reported without a country-specific status.

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed — this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest

Times are UTCNewest first

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Citicoline article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.